Table 2 Baseline program characteristics and sensitisation methods of programs according to vaccine uptake rate (VUR) and D3-D1 adherence to HPV-vaccination, Gardasil Access Program, 2009–2013 (N = 21 programs)
From: Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
Mean VUR (SD) % | p | Mean D3-D1* adherence to vaccination (SD) % | p | |
|---|---|---|---|---|
Managing institution | ||||
MoH (n = 13) | 87.2 (10.7) | 0.05 | 90.8 (7.1) | 0.99 |
NGO (n = 8) | 96.0 (7.4) | 90.8 (8.1) | ||
Institution services Cancer management | ||||
Presence (n = 14) | 91.6 (11.3) | 0.51 | 91.7 (7.8) | 0.43 |
Absence (n = 7) | 88.4 (8.5) | 89.0 (6.5) | ||
Health care services | ||||
Presence (n = 16) | 89.8 (10.6) | 0.56 | 90.2 (7.8) | 0.51 |
Absence (n = 5) | 93.0 (10.3) | 92.8 (5.5) | ||
Vaccination services | ||||
Presence (n = 20) | 91.1 (10.3) | 0.25 | 90.9 (77.5) | 0.87 |
Absence (n = 1) | 80.2 (-) | 89.9 (-) | ||
Vaccination delivery model | ||||
HC (n = 5) | 89.8 (13.6) | 90.1 (9.5) | ||
Schools (n = 12) | 93.1 (8.8) | 0.30 | 92.5 (7.3) | 0.52 |
Mixed (n = 4) | 83.8 (9.7) | 87.9 (5.1) | ||
Community involvement actions | ||||
Communication key messages definition | ||||
Yes (n = 11) | 94.1 (11.4) | 0.27 | 92.5 (7.5) | 0.29 |
No (n = 10) | 88.8 (9.2) | 89.0 (7.0) | ||
Girls follow-up | ||||
Yes (n = 13) | 95.4 (9.4) | 0.05 | 91.4 (7.5) | 0.67 |
No (n = 8) | 86.1 (10.8) | 89.9 (7.4) | ||
Vaccination sessions announcement | ||||
Yes (n = 11) | 93.0 (9.4) | 0.28 | 89.3 (9.2) | 0.35 |
No (n = 10) | 88.8 (11.5) | 92.4 (4.3) | ||
Girls recruitment | ||||
Yes (n = 14) | 89.3 (10.7) | 0.44 | 90.3 (8.3) | 0.62 |
No (n = 7) | 93.1 (9.9) | 92.0 (5.3) | ||
Number of community involvements actions | ||||
0 (n = 3) | 88.0 (12.1) | 90.4 (4.2) | ||
1-2 (n = 7) | 85.7 (10.0) | 0.20 | 89.1 (7.6) | 0.72 |
3-4 (n = 11) | 94.4 (9.5) | 92.1 (8.0) | ||
At least one community involvement action | ||||
0 (n = 3) | 88.0 (12.1) | 0.56 | 90.4 (4.2) | 0.92 |
> = 1 (n = 18) | 92.0 (10.7) | 90.9 (7.8) | ||
Communication key messages and methods | ||||
Vaccine administration modalities | ||||
Yes (n = 13) | 89.4 (10.2) | 0.65 | 90.3 (8.2) | 0.70 |
No (n = 8) | 92.4 (10.2) | 91.6 (6.0) | ||
Vaccine safety and efficacy | ||||
Yes (n = 15) | 93.3 (9.1) | 0.05 | 92.3 (6.9) | 0.15 |
No (n = 6) | 83.6 (10.8) | 87.2 (7.6) | ||
HPV and link to cancer | ||||
Yes (n = 15) | 88.4 (10.3) | 0.13 | 88.8 (7.3) | 0.04 |
No (n = 6) | 95.9 (8.9) | 95.9 (4.6) | ||